Iredale J. End-stage chronic liver disease: time to define a good death. Hepatology. 2008 Jun;47(6):1799-800. PubMed PMID: 18508308. Epub 2008/05/30. eng.Iredale J. End-stage chronic liver disease: time to define a good death. HEPATOLOGY 2008;47:1799-1800....
229 kidney cells. Heritability analysis reveals that methylation variation explains a larger fraction of heritability than gene expression. We present a multi-stage prioritization strategy and prioritize target genes for 87% of kidney function loci. We highlight key roles of proximal tubules and ...
We first performed feature selection to select the top disease biomarkers. Instead of using a simple one-shot feature selection technique that usually yields a sub-optimal solution, we used a two-step feature selection process that generates better performance: backward feature elimination followed by ...
We first performed feature selection to select the top disease biomarkers. Instead of using a simple one-shot feature selection technique that usually yields a sub-optimal solution, we used a two-step feature selection process that generates better performance: backward feature elimination followed by ...
Up to 70% of all AAV patients develop glomerulonephritis (ANCA GN) warranting immediate treatment to prevent chronic kidney damage [2,3]. However, there are still patients who progress to end-stage kidney disease (ESKD) [2,3] highlighting that establishing true disease quiescence remains a ...
stage to create a point map. Each point on the map represents one of the statements from the final statement list. The closer the point is to another indicates they were sorted together by the majority of participants. Hierarchical cluster analysis is used to identify the clusters in the map...